These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36443635)
1. Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery. Kheoane PS; Enslin GM; Tarirai C Drug Deliv Transl Res; 2023 May; 13(5):1358-1371. PubMed ID: 36443635 [TBL] [Abstract][Full Text] [Related]
2. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer. Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316 [TBL] [Abstract][Full Text] [Related]
3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
4. 2-Dioleoyl-sn-glycero-3-phosphocholine-based nanoliposomes as an effective delivery platform for 17β-estradiol. Bowey K; Tanguay JF; Tabrizian M Eur J Pharm Biopharm; 2014 Apr; 86(3):369-75. PubMed ID: 24161656 [TBL] [Abstract][Full Text] [Related]
5. Effect of Lipid Composition on the Interaction of Liposomes with THP-1-Derived Macrophages. Ibuki R; Tokui T; Kuriyama M; Hosoda K; Tomoda H; Sakai-Kato K Biol Pharm Bull; 2024; 47(3):723-731. PubMed ID: 38538335 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Alipour M; Halwani M; Omri A; Suntres ZE Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881 [TBL] [Abstract][Full Text] [Related]
7. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol. Basavaraj S; Betageri GV Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117 [TBL] [Abstract][Full Text] [Related]
8. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980 [TBL] [Abstract][Full Text] [Related]
9. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids. Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914 [TBL] [Abstract][Full Text] [Related]
10. Double loading of cyclosporine A in liposomes using cyclodextrin complexes. Malaekeh-Nikouei B; Davies N PDA J Pharm Sci Technol; 2009; 63(2):139-48. PubMed ID: 19634352 [TBL] [Abstract][Full Text] [Related]
12. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes. Tang WL; Tang WH; Chen WC; Diako C; Ross CF; Li SD Mol Pharm; 2017 Jun; 14(6):1969-1979. PubMed ID: 28460165 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity. Pereira S; Egbu R; Jannati G; Al-Jamal WT Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659 [TBL] [Abstract][Full Text] [Related]
14. The effect of thermosensitive liposomal formulations on loading and release of high molecular weight biomolecules. Huang X; Li M; Bruni R; Messa P; Cellesi F Int J Pharm; 2017 May; 524(1-2):279-289. PubMed ID: 28377318 [TBL] [Abstract][Full Text] [Related]
15. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors. Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968 [TBL] [Abstract][Full Text] [Related]
16. Optimization of liposomal topotecan for use in treating neuroblastoma. Chernov L; Deyell RJ; Anantha M; Dos Santos N; Gilabert-Oriol R; Bally MB Cancer Med; 2017 Jun; 6(6):1240-1254. PubMed ID: 28544814 [TBL] [Abstract][Full Text] [Related]
17. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof. Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189 [TBL] [Abstract][Full Text] [Related]